EnCor EnCompass™ Breast Biopsy and Tissue Removal System

FDA 510(k) K262571 · Bard Peripheral Vascular, Inc.

Substantially Equivalent

510(k) numberK262571

Submission

Device name
EnCor EnCompass™ Breast Biopsy and Tissue Removal System
Applicant
Bard Peripheral Vascular, Inc.
Tempe, AZ, US
Received
July 24, 2026
Decision date
August 14, 2026
Decision
Substantially Equivalent (SESE)
Type
Special 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
KNW – Instrument, Biopsy
Device class
Class II (moderate risk)
Regulation
21 CFR 876.1075
Specialty
Gastroenterology, Urology

Other 510(k)s with product code KNW

510(k)DeviceApplicantDecision
K260517Automatic Core Biopsy InstrumentKNW · Traditional Zhejiang Curaway Medical Technology Co., Ltd.08/28/2026SE
K262792Brevera Biopsy System with CorLumina Imaging Technology (BREVDISP09)KNW · Special Hologic, Inc.08/12/2026SE
K260572Marrow MarxmanKNW · Traditional Medimetrix, LLC08/04/2026SE
K261196Promisemed VeriEcto Automatic Biopsy NeedlesKNW · Special Promisemed Hangzhou Meditech Co., Ltd.05/12/2026SE
K260365Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Control Module; Mammotome…KNW · Traditional Devicor Medical Products, Inc.03/04/2026SE
K252795ZeniCore™ Automatic Biopsy Instrument (863212100 / ZeniCore Automatic Biopsy Device 12ga…KNW · Traditional Argon Medical Devices, Inc.02/23/2026SE
K252681EnCor EnCompass™ Breast Biopsy and Tissue Removal SystemKNW · Traditional Bard Peripheral Vascular, Inc.12/12/2025SE
K252183Resitu Slider 09 (RESL09)KNW · Traditional Resitu Medical AB09/24/2025SE
K243407Forcyte Autograft Harvest KitKNW · Traditional Forcyte Medical, LLC07/29/2025SE
K244018Disposable Biopsy NeedleKNW · Traditional Zhejiang Curaway Medical Technology Co., Ltd.07/22/2025SE

More from Zhejiang Curaway Medical Technology Co., Ltd.

510(k)DeviceDecision
K260012UltraScore™ Focused Force PTA BalloonPNO · Special 02/04/2026SE
K252681EnCor EnCompass™ Breast Biopsy and Tissue Removal SystemKNW · Traditional 12/12/2025SE
K250032Marquee™ Disposable Core Biopsy Instrument and Instrument KitKNW · Special 07/10/2025SE
K250219Dorado™ PTA Balloon Dilatation CatheterDQY · Traditional 06/17/2025SE
K243642UltraCor™ Twirl™ Breast Tissue MarkerNEU · Traditional 03/24/2025SE
K242757Rotarex Atherectomy SystemMCW · Special 01/30/2025SE
K241946PeritX™ 1L Drainage Kit (90-1010); PeritX™ 2L Drainage Kit (90-2010); PeritX™ Peritoneal…PNG · Traditional 12/06/2024SE
K232737PowerPort™ ClearVUE™ Slim ECG Enabled Implantable Port; PowerPort™ ClearVUE™ isp ECG…LJT · Special 12/08/2023SE
K221440Liverty™ TIPS Access SetDYB · Traditional 05/31/2022SE
K213896BD Trek Powered Bone Biopsy SystemKNW · Traditional 03/30/2022SE

Questions and answers

When was EnCor EnCompass™ Breast Biopsy and Tissue Removal System cleared by the FDA?

EnCor EnCompass™ Breast Biopsy and Tissue Removal System (K262571) received a 510(k) decision of Substantially Equivalent on August 14, 2026, 21 days after the submission was received.

What is the product code of K262571?

The FDA product code is KNW – Instrument, Biopsy, a Class II (moderate risk) device regulated under 21 CFR 876.1075.